Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 968.12% | 14,815.81% | 44,945.00% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,275.25% | 16,688.46% | 44,945.00% | -- | -- |
| Operating Income | -1,275.25% | -16,688.46% | -44,945.00% | -- | -- |
| Income Before Tax | -745.58% | -241.63% | -19,425.93% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -745.58% | -241.63% | -19,425.93% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -745.58% | -241.63% | -19,425.93% | -- | -- |
| EBIT | -1,275.25% | -16,688.46% | -44,945.00% | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -135.51% | -9.72% | -9,688.76% | -- | -- |
| Normalized Basic EPS | -135.51% | -9.71% | -9,621.43% | -- | -- |
| EPS Diluted | -135.51% | -9.72% | -9,688.76% | -- | -- |
| Normalized Diluted EPS | -135.51% | -9.71% | -9,621.43% | -- | -- |
| Average Basic Shares Outstanding | 640.67% | 475.77% | 287.82% | -- | -- |
| Average Diluted Shares Outstanding | 640.67% | 264.35% | 71.89% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |